Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026)

Lensar's (LNSR) quarterly Depreciation & Amortization (CF) came in at $904000.0 in Q1 2026, up 7.11% year-on-year from $844000.0 in Q1 2025, and down 4.24% on a QoQ basis from $944000.0 in Q4 2025.

Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $904000.0 in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 7.11% year-over-year to $904000.0 in Q1 2026; TTM through Mar 2026 was $3.6 million, a 15.29% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 20.94% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $904000.0, down from $944000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for LNSR reached as high as $944000.0 in Q4 2025 and fell as low as $541000.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $713058.8 across 5 years, with a median of $651000.0 in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 66.37% in 2022 and grew 1.93% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $577000.0 in 2022, then increased by 12.82% to $651000.0 in 2023, then jumped by 34.25% to $874000.0 in 2024, then advanced by 8.01% to $944000.0 in 2025, then retreated by 4.24% to $904000.0 in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $904000.0 in Q1 2026, $944000.0 in Q4 2025, and $928000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Lensar 70.05 Mn 72.73 Mn 6.38 Mn 904,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 904,000.00
Mar 31, 2026 904,000.00
Dec 31, 2025 944,000.00
Dec 31, 2025 944,000.00
Sep 30, 2025 928,000.00
Sep 30, 2025 928,000.00
Jun 30, 2025 865,000.00
Jun 30, 2025 865,000.00
Mar 31, 2025 844,000.00
Mar 31, 2025 844,000.00
Dec 31, 2024 874,000.00
Dec 31, 2024 874,000.00
Sep 30, 2024 774,000.00
Sep 30, 2024 774,000.00
Jun 30, 2024 666,000.00
Jun 30, 2024 666,000.00
Mar 31, 2024 647,000.00
Mar 31, 2024 647,000.00
Dec 31, 2023 651,000.00
Dec 31, 2023 651,000.00